Spectrum Pharmaceuticals Inc (SPPI) Return on Equity ROE from the first quarter 2023 to first quarter 2022 and annually, average high and low, overall ranking from Mar 31 2023 to Mar 31 2022 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Spectrum Pharmaceuticals Inc   (NASDAQ: SPPI)

Spectrum Pharmaceuticals Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Spectrum Pharmaceuticals Inc in the first quarter 2023?
Spectrum Pharmaceuticals Inc recorded a cumulative net loss of $-65 million during 12 months ending in the first quarter 2023, resulting in a negative return on equity (ROE) of -209.59%.

Within the Major Pharmaceutical Preparations industry 407 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the fourth quarter 2022 from 0 to 4224.

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter		 (Mar 31 2022)
I. Quarter
Y / Y Equity Change -51.49 % -41.35 % -54.88 % -69.2 % -
Y / Y Net Income Change - - - - -
Net Income (TTM) in Millions -65 -75 -106 -117 -138
Return On Equity (TTM) -209.59 % -197.85 % -246.67 % -217.49 % -190.29 %
SPPI's Total Ranking # 4224 # 0 # 0 # 0 # 0
Equity (TTM) in Millions 27 28 36 33 55
Seq. Equity Change -3.88 % -22.21 % 7.21 % -39.48 % 16.2 %
Seq. Net Income Change - - - - -

Back to SPPI Management Effectiveness >> SPPI's 5 Years Annual ROE >> Compare SPPI ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry # 408
Sector # 826
Overall # 4224

Return On Equity Statistics
High Average Low
43.13 %
-59.4 %
-246.67 %
(Jun 30 2012)   (Sep 30 2022)





SPPI Annual Return On Equity (Dec 31 2022)
2022		 (Dec 31 2021)
2021		 (Dec 31 2020)
2020		 (Dec 31 2019)
2019		 (Dec 31 2018)
2018
Total Equity in Millions 28 48 134 190 283
Y / Y Equity Change -41.35 % -64.58 % -29.49 % -32.79 % -19.38 %
Net Income in Millions -75 -159 10 32 0
Y / Y Net Income Change - - -67.2 % - -
Return On Equity -270.37 % -333.58 % 7.79 % 16.76 % -0 %

Back to SPPI Management Effectiveness >> SPPI's 5 Years Annual ROE >> Compare SPPI ROE to its Competitors




More Return On Equity Ratios
Major Pharmaceutical Preparations Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
SPPI's' Return on Equity at Yahoo Finance
SPPI's Roe Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for SPPI's Competitors
Subscribers only: Roe for Spectrum Pharmaceuticals Inc 's Suppliers
Subscribers only: Return On Equity for SPPI's Customers




Companies with similar Return On Equity at Mar 31 2023, within Healthcare Sector ROE

Date modified: 2026-09-08T15:10:57+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.